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This is an open access article under the CC BY-NC-ND license (http://creativFig. 1. (a) ‘‘Myokymic” fibrillations, apparently elicited by slow-rising ‘‘giant
MEPPs”. Note the bursting pattern and the high frequency at the presumed peak of
the acetylcholine release, and decrease of the frequency towards the end of a
sequence. The high frequency is possible because the muscle fiber is not denervated
and thus the refractory period after the action potential is normal, contrary to
fibrillations after denervation of the muscle fiber. (b) A single averaged potential.
The initial positive deflection is 1.2 ms and amplitude 0.6 mV.Spontaneous fibrillation potentials in EMG are a sign of dener-
vation of a muscle fiber, as in motor axonal damage, or a part of a
muscle fiber, as for example in necrotizing myopathy. Both rhyth-
mic and irregular fibrillations have been described (Buchthal and
Rosenfalck, 1966; Partanen and Danner, 1982). The underlying
pathophysiology is different in rhythmic fibrillations and irregular
fibrillations. Rhythmic fibrillations are a consequence of the slow
rhythmic oscillations of an instable muscle membrane potential
after denervation: Every depolarization wave reaching the firing
threshold elicits a fibrillation potential. Irregular fibrillations are
elicited by randomly occurring ‘‘fibrillatory origin potentials”
(FOPs), arising in highly localized regions (<100 mm) of denervated
muscle fibers, possibly associated with T-tubules (Purves and
Sakmann, 1974). When a FOP reaches the threshold level and elic-
its a propagating fibrillation potential spreading to both ends of
the denervated fiber, there is a long refractory period (Thesleff,
1982a), which prevents the early activation of a new fibrillation
potential. Irregular spontaneous activity at the endplate region is
a normal finding, not indicative of pathology, but it should be
easily recognised and is the reason why fibrillation activity should
be recorded from a number of sites (three) within a muscle before
it is considered pathological.
A patient with a third type of fibrillation-like activity,
‘‘myokymic fibrillation” is described. ‘‘Myokymic fibrillation” is
not a sign of denervation of the muscle fiber. The particular prop-
erty of this type of spontaneous activity is the fact that the refrac-
tory time of the muscle fiber is not increased, as it is in fibrillations
caused by denervation (Thesleff, 1982a). It should be noted that
the term ‘‘myokymic fibrillation” is only descriptive, and not
connected to the pathophysiology of true myokymia caused by
spontaneous activation of motor nerve fibers. ‘‘Myokymic fibrilla-
tion” is distinctly different from end plate spikes (EPSs): It can be
recorded for a long time with a similar bursting firing pattern,
when the EMG needle is not moved whereas EPSs slow down
(Partanen, 2013).
A 52-year-old woman developed clumsy right lower leg during
winter 2015. The situation deteriorated rapidly and the patient
expressed widespread muscle denervation in ENMG study in fall
2016 and motor neuron disease was diagnosed. At that time there
was also spasticity in the right upper extremity and bilateral lower
extremities, as well as clonic reflexes in the lower extremities.
There was also weakness of the neck.
A peculiar spontaneous EMG activity, ‘‘myokymic fibrillation”,
was observed in the right trapezius muscle (Fig. 1). It consisted
of sequences of potentials, which lasted ad 6 s. The interpotential
intervals tended to be short initially but longer towards the end
of a sequence. The potentials were fibrillation-like, i.e. derivedPublished by Elsevier B.V.
ecommons.org/licenses/by-nc-nd/4.0/).
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itive deflection of a single potential was 1.2 ms and amplitude
0.6 mV (Fig. 1) and thus the wave form differed from that of an
EPS (Partanen, 2013). The given muscle showed also signs of ongo-
ing axonal damage: rhythmic fibrillation potentials and also motor
unit potential alterations caused by motor nerve sprouting, as well
as reduced interference pattern. I conjecture that ‘‘myokymic fib-
rillation” may represent spontaneous release of acetylcholine from
a motor nerve terminal, eliciting a ‘‘slow-rising giant miniature
end plate potential (giant MEPP)” (Thesleff, 1982b; Thesleff and
Molgó, 1983; Sellin et al., 1996). This type of transmitter release
may occur spontaneously in regenerating motor nerve terminal,
but it has also been described after botulin toxin injection or appli-
cation of 4-aminoquinoline (Thesleff, 1982b). A ‘‘Giant MEPP” evi-
dently causes a series of postsynaptic action potentials in the
postjunctional muscle fiber, and during the peak of the release
the mean frequency of potentials is higher than towards the end
of the series when acetylcholine dehydrogenase diminishes the
concentration of the transmitter. The muscle fiber is not dener-
vated and thus the refractory period after an action potential is
normal.
In our patient this activity may be connected with a regenerat-
ing motor nerve terminal (Thesleff and Molgó, 1983). We observed
this activity only in the trapezius muscle. In some other patients
this activity was expressed in several muscles. However, this kind
of spontaneous activity is very rare. Since I learned to distinguish it
from other forms of spontaneous activity I have found it at most
1–2 times per year in my ENMG work consisting of about 2000
patients annually. The comparison of the firing pattern and wave
form of ‘‘myokymic fibrillation” and other types of fibrillations to
EPSs was published elsewhere (Partanen, 1999, 2013). In short,
in the firing pattern the average proportional consecutive interval
difference (APCID) and the minimum interval were different
(p < 0.05) when ‘‘myokymic fibrillation” was compared to EPSs,
and EPSs did not show a bursting pattern, as ‘‘myokymic fibrilla-
tions” did. As to the wave form, the fibrillations had a mean initial
positive deflection of 1.6 ms (SE 0.4), whereas 36% of EPSs showeda mean initial positive deflection of 0.5 ms (SE 0.2) (p < 0.001), and
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